Insmed INSM
NASDAQ INSM
$95.47 -0.20 (-0.21%)
As of: Oct 21, 2026 · 11:41 AM EDT

Insmed (INSM) Other financing activities (2014 - 2024)

Updated

Insmed's Other financing activities was $3.74 million in Q4 2024.

Analysis

Insmed (INSM) Other financing activities (2014 - 2024) Analysis & Trends

From Q4 2014 onward, Insmed has reported Other financing activities for 12 quarters.

  • Other financing activities shows a five-year compound annual growth rate of -3.7% (FY2019 to FY2024).
  • In earlier years, Other financing activities was $1.22 million in FY2023 (-93.2%), $17.78 million in FY2022 (+13.1%), $15.72 million in FY2021 and -$936,000 in FY2020.
  • The Q4 2024 figure marks the highest quarterly Other financing activities since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Insmed 20.75 Bn 15.26 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -3.74 Mn
Jun 30, 2024 409,000.00
Mar 31, 2024 -409,000.00
Mar 31, 2023 -1.22 Mn
Dec 31, 2022 -17.78 Mn
Dec 31, 2021 -16,000.00
Sep 30, 2021 311,000.00
Dec 31, 2020 -936,000.00
Dec 31, 2019 4.50 Mn
Dec 31, 2018 2.83 Mn
Jun 30, 2018 -94,000.00
Mar 31, 2018 -16.98 Mn
Dec 31, 2016 -103,000.00
Dec 31, 2014 -150,000.00
API Access

Insmed Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=INSM&period=max&api_key=YOUR_API_KEY